GILL DAVID N

• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Earnings

Download results Settings

Abbreviations B: Buy, S: Sell, PP: Planned purchase, PS: Planned sale, O: Option / Other

Notification date	Transaction date	B/S Transaction type	Nb. shares Price Value	Number of shares	Price	Value	Details
2024-05-15	2024-05-14	Evolus Inc (EOLS)	S Sale	6,718 -16.5% 12.60 USD 84,654	6,718 -16.5%	12.60	USD 84,654
2024-05-15	2024-05-13	Evolus Inc (EOLS)	S Sale	3,643 -8.2% 12.72 USD 46,356	3,643 -8.2%	12.72	USD 46,356
2022-05-17	2022-05-16	Evolus Inc (EOLS)	S Sale	5,000 -14.5% 13.62 USD 68,080	5,000 -14.5%	13.62	USD 68,080
2022-05-17	2022-05-13	Evolus Inc (EOLS)	S Sale	5,313 -13.3% 13.10 USD 69,584	5,313 -13.3%	13.10	USD 69,584
2021-01-20	2021-01-19	Y-mAbs Therapeutics, Inc (YMAB)	PS Planned sale	2,000 -100.0% 46.52 USD 93,045	2,000 -100.0%	46.52	USD 93,045
2020-11-20	2020-11-18	Y-mAbs Therapeutics, Inc (YMAB)	PS Planned sale	2,000 -100.0% 45.77 USD 91,530	2,000 -100.0%	45.77	USD 91,530
2020-11-05	2020-11-03	Y-mAbs Therapeutics, Inc (YMAB)	PS Planned sale	4,000 -100.0% 45.00 USD 180,000	4,000 -100.0%	45.00	USD 180,000
2020-09-28	2020-09-24	Strongbridge Biopharma plc (SBBP)	B Purchase	8,000 +12.0% 2.13 USD 17,040	8,000 +12.0%	2.13	USD 17,040
2019-06-14	2019-06-13	Evolus Inc (EOLS)	B Purchase	2,000 +66.7% 13.65 USD 27,300	2,000 +66.7%	13.65	USD 27,300
2004-05-13	2004-05-11	CTI Molecular Imaging Inc (CTMI)	S Sale	10,000 -40.0% 14.07 USD 140,700	10,000 -40.0%	14.07	USD 140,700